United States v. Univis Lens Co.

316 U.S. 241, 62 S. Ct. 1088, 86 L. Ed. 1408, 1942 U.S. LEXIS 1241, 53 U.S.P.Q. (BNA) 404
CourtSupreme Court of the United States
DecidedMay 11, 1942
DocketNos. 855, 856
StatusPublished
Cited by227 cases

This text of 316 U.S. 241 (United States v. Univis Lens Co.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Univis Lens Co., 316 U.S. 241, 62 S. Ct. 1088, 86 L. Ed. 1408, 1942 U.S. LEXIS 1241, 53 U.S.P.Q. (BNA) 404 (1942).

Opinion

Mr. Chief Justice Stone

delivered the opinion of the Court.

These cases come here on direct appeal and cross appeal from a judgment of the District Court granting in part and denying in part the Government’s prayer for an in *243 junction restraining violations of § § 1 and 3 of the Sherman Act, 15 U. S. C. §§ 1,3, which make unlawful any contract, combination or conspiracy in restraint of trade or commerce among the states. The principal questions for decision are:

First: Whether the system established and maintained by the Univis Corporation, appellee and cross appellant, for licensing the manufacture and sale of patented multifocal eyeglass lenses is excluded by the patent monopoly from the operation of the Sherman Act.

Second: Whether if not so excluded the resale price provisions of the licensing system are within the prohibition of the Sherman Act and not exempted from it by the provisions of the Miller-Tydings Act amendment of § 1 of the Sherman Act, 50 Stat. 693.

Appellee, Univis Lens Company, was the owner of a number of patents and two trademarks relating to multifocal lenses. In 1931 it organized appellee, Univis Corporation. The Lens Company then acquired and now holds a majority of the stock of the Corporation. The individual appellees are the principal stockholders of the Lens Company. They are stockholders in the Corporation and are the principal officers of both corporations, which may for the purposes of this suit be treated as though they were a single corporation. Upon the organization of the Corporation, the Lens Company transferred to it all its interest in the patents and trademarks presently involved, and the Corporation then proceeded to set up and has since maintained the licensing system which the Government now assails.

The relevant features of the system are as follows: The Corporation licenses the Lens Company to manufacture lens blanks and to sell them to designated licensees of the Corporation, upon the Lens Company’s payment to the Corporation of an agreed royalty of 50 cents a pair. *244 The lens blanks are rough opaque pieces of glass of suitable size, design and composition for use, when ground and polished, as multifocal lenses in eyeglasses. Each blank is composed of two or more pieces of glass of different refractive power, of such size, shape, and composition and so disposed that when fused together in the blank it is said to conform to the specifications and claims of some one of the Corporation’s patents.

The Corporation also issues three classes of licenses— licenses to wholesalers, to finishing retailers and to prescription retailers. The licenses to wholesalers authorize the licensees to purchase the blanks from the Lens Company, to finish them by grinding and polishing, and to sell them to prescription licensees only at prices fixed by the Corporation licensor. In finishing the lenses so as to make them an effective aid to vision of the prospective wearer, to whom the prescription retailer sells, it is necessary for the wholesaler, by grinding the blanks, to conform their curvatures to the prescription supplied by the retailer with his order. By the terms of the license the wholesalers are required to keep full accounts of all sales, showing the sales prices of lenses and the names of the purchasers, and to make them available to representatives of the Corporation.

The licenses to finishing retailers—who purchase the blanks from the Lens Company, grind and polish them and adjust the lenses, in frames or supports, to the eyes of the consumers—contain similar provisions. The retailers are licensed to purchase the blanks of the Lens Company and to sell them to their customers at prices prescribed by the Corporation licensor.

Both the licenses to wholesalers and to finishing retailers require the licensee to notify the Corporation “of any violation on the part of any jobbers or other licensees of the agreements respectively made by them with the Corporation, and to assist the Corporation in all possible ways *245 in securing evidence against, and enforcing its agreements with such jobbers and licensees.”

The licenses to prescription retailers, who are without facilities for grinding and finishing the lenses, but who prescribe and adjust glasses for their customers, are signed both by the Corporation and a licensor wholesaler, and grant to the retailer a “franchise to prescribe and fit Univis lenses,” in return for which the prescription retailer agrees to sell finished lenses only to consumers and only at prices prescribed by the Corporation.

All the licenses to wholesalers and retailers recite the Corporation’s ownership of the lens patents and purport to confer on the licensee the privilege of selling the patented invention in the manner and to the extent stated. No royalties are exacted of any of the licensees other than the 50 cents collected by the Corporation for each pair of blanks sold by the Lens Company. The rewards of the corporate appellees for the exploitation of the patents and the patented lenses are derived wholly from the sales by the Lens Company of the blanks, from the proceeds of which the 50 cent royalty is paid.

The prices prescribed and maintained under the licensing system are: $3.25 a pair for the blanks sold by the Lens Company to wholesalers, and $4 a pair for those sold to finishing retailers; $7 a pair for finished lenses sold by wholesalers; $16 a pair for white, and $20 for tinted, lenses sold to consumers by prescription and finishing retailers.

The Corporation pursues the policy of issuing licenses to “qualified licensees” who, it is said, are required to maintain “high standards of practice” and to be skilled in the performance of the services which they undertake to render. According to the Corporation’s instructions to its field representatives, “price cutters” are not eligible as prescription retailer licensees. Inquiry is made to ascertain whether prospective licensees advertise prices, and whether they are considered in their communities to *246 be price cutters. The Corporation cancels licenses principally because of the failure of licensees to adhere to the price fixing provisions but also because they advertise prices or the acceptance of installment payments, or for other forms of advertising objectionable to it; for selling Univis lenses to customers other than those designated by the Corporation; for not giving a certain percentage of the licensees’ multifocal lens business to Univis; because the licensee is located in a drug, department or jewelry store, or because the licensee engaged in price cutting in the sale of the products of other manufacturers.

For a time the Corporation licensed approximately 20 per cent of the retailers in a locality. It now licenses a larger percentage but not more than 50 per cent. There are approximately 330 wholesaler licensees, 325 finishing retailer licensees and 6,500 prescription retailer licensees located in various states of the Union, including New York and the District of Columbia.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Basf Corporation v. Snf Holding Company
955 F.3d 958 (Federal Circuit, 2020)
Impression Products, Inc. v. Lexmark Int'l, Inc.
581 U.S. 360 (Supreme Court, 2017)
High Point Sarl v. T-Mobile USA, Inc.
640 F. App'x 917 (Federal Circuit, 2016)
Helferich Patent Licensing, LLC v. New York Times Co.
778 F.3d 1293 (Federal Circuit, 2015)
Lifescan, Inc. v. Shasta Technologies, LLC
933 F. Supp. 2d 1243 (N.D. California, 2013)
Princo Corp. v. International Trade Commission
616 F.3d 1318 (Federal Circuit, 2010)
LG Electronics, Inc. v. Asustek Computer, Inc.
248 F. Supp. 2d 912 (N.D. California, 2003)
Monsanto Co. v. Scruggs
249 F. Supp. 2d 746 (N.D. Mississippi, 2001)
Minebea Co., Ltd. v. Papst
13 F. Supp. 2d 35 (District of Columbia, 1998)
Glass Equipment Development, Inc. v. Simonton Windows Co.
929 F. Supp. 227 (N.D. West Virginia, 1996)
Hoppe v. Baxter Healthcare Corp.
878 F. Supp. 303 (D. Massachusetts, 1995)
Asgrow Seed Co. v. Winterboer
513 U.S. 179 (Supreme Court, 1995)
Universal Electronics, Inc. v. Zenith Electronics Corp.
846 F. Supp. 641 (N.D. Illinois, 1994)
Cyrix Corp. v. Intel Corp.
846 F. Supp. 522 (E.D. Texas, 1994)
Met-Coil Systems Corp. v. Korners Unlimited, Inc.
628 F. Supp. 130 (W.D. Pennsylvania, 1986)
Robb Container Corp. v. Sho-Me Co.
566 F. Supp. 1143 (N.D. Illinois, 1983)
Sanofi, S.A. v. Med-Tech Veterinarian Products, Inc.
565 F. Supp. 931 (D. New Jersey, 1983)

Cite This Page — Counsel Stack

Bluebook (online)
316 U.S. 241, 62 S. Ct. 1088, 86 L. Ed. 1408, 1942 U.S. LEXIS 1241, 53 U.S.P.Q. (BNA) 404, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-univis-lens-co-scotus-1942.